Harbour Investments’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-158
Closed -$39K 3148
2022
Q3
$39K Hold
158
﹤0.01% 1370
2022
Q2
$39K Buy
+158
New +$42.6K ﹤0.01% 1370
2021
Q4
$57K Sell
158
-4
-2% -$1.35K ﹤0.01% 1204
2021
Q3
$53K Sell
162
-299
-65% -$101K ﹤0.01% 1735
2021
Q2
$144K Hold
461
﹤0.01% 1205
2021
Q1
$147K Buy
+461
New +$148K 0.01% 1123

Other funds holding ABMD

Harbour Investments's ABMD Position: Q4 2022 in Review

Harbour Investments sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 158 shares — an estimated $39K sold.

Harbour Investments first reported a position in ABMD in Q1 2021 and held it in 6 quarters. The position peaked at $147K in Q1 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Harbour Investments reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Harbour Investments sold 158 Abiomed Inc shares in Q4 2022, an estimated $39K.
  • Harbour Investments first reported a position in Abiomed Inc in Q1 2021 and held it in 6 quarters.
  • Harbour Investments's Abiomed Inc position peaked at $147K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Harbour Investments's 13F filing for Q4 2022, filed 16 Feb 2023.